Securities

The potential rescheduling of cannabis may do little immediately to ease the path for cannabis companies to list on U.S. stock...

CRB Monitor is closely following the latest developments in cannabis rescheduling. Question: Were cannabis investors given the straight scoop about...

It has been more than 19 months since President Joe Biden injected life (or at least, hope) into the cannabis...

Cannabis Equity Returns The Nasdaq CRB Monitor Global Cannabis Index (HERBAL) had a positive 24.2% return for the 3rd quarter...

This month, we turn our attention to the Sunshine State, where the Florida Supreme Court has issued its decision that...

What a silly question, given that cannabis equities have to stage a quadruple-digit comeback to fully recover from their highs...

It has been about a year since we have written about the sometimes dysfunctional relationship amongst Tier 1 Pure Play,...

February reminded us once again that “we can’t have nice things” in the cannabis market, at least not for very...

January 2024 provided further evidence that the cannabis industry not only has a pulse but might actually pull itself together...

The CRB Monitor Securities Research team covers all aspects of the publicly-traded cannabis ecosystem, including the regulatory environment, operational expansion/M&A...